Latest Headlines

  1. Cellular Origins And 3P innovation Collaborate To Accelerate Industrialisation Of CGT Manufacturing 5/21/2025

    Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced a collaboration with 3P innovation, a leading engineering company and supplier of automated fill-finish equipment.

  2. ACG Unveils Patented Personalized Capsule Technology 5/20/2025

    ACG, a global provider of fully integrated manufacturing solutions for the pharmaceutical and nutraceutical industries, introduces its world-first Personalised Capsule Machine (PCM) – a patented technology that creates custom-formulated supplement capsules tailored to individual needs on demand. The PCM merges real-time health data, precision dosing, and automated capsule production to create individualised supplements.

  3. ISPE Announces 2025 Facility Of The Year Award Category Winners 5/16/2025

    We are thrilled to unveil the exceptional projects selected as category winners for the 2025 ISPE Facility of the Year Awards (FOYA). These distinguished companies were selected not only for their outstanding achievements in engineering and design but also for their commendable contributions to their communities and profound impact on human lives.

  4. SK pharmteco Expands Stability Storage Capacity In California To Support Small Molecule Drug Substance And Drug Product Programs 5/15/2025

    SK pharmteco, a global contract development and manufacturing organization (CDMO), announces the expansion of its stability storage capacity at its El Dorado Hills, California facility.

  5. CDMO Piramal Pharma Solutions Announces $90 Million Investment Into US Manufacturing Facilities 5/14/2025
  6. Ratio Therapeutics to Construct New Radiopharmaceutical Manufacturing 5/14/2025

    Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced that it entered into an agreement with the Medical Innovation Technology Management division of Wasatch Group to partner and construct a state-of-the-art radiopharmaceutical research and manufacturing facility in Salt Lake City, Utah, anticipated to be fully operational in the second half of 2027.

  7. ISPE Announces 2025 Facility Of The Year Awards (FOYA) Category Winners, Celebrating FOYA's 20th Anniversary Year 5/13/2025

    FOYA Judges name six category winners plus two honorable mentions at the 2025 ISPE Europe Annual Conference in London, United Kingdom (UK)..

  8. Genentech Announces Significant Investment For New Fill/Finish Drug Manufacturing Facility In North Carolina 5/12/2025

    Genentech, a member of the Roche Group based in Switzerland, has announced plans to invest $700 million in Holly Springs to establish a new high-volume fill/finish manufacturing facility.

  9. Gilead Announces $32 Billion Investment Into US Drug Manufacturing 5/8/2025

    Gilead Sciences is committed to advancing world-class science and driving innovation — with the United States at the heart of our operations. Today, our U.S. R&D and manufacturing footprint is our largest globally. Our U.S. R&D and manufacturing investments in the U.S. will create $43 billion in value to the U.S. economy over the next five years through direct capital investment and job creation. This comprehensive investment further bolsters Gilead’s domestic research, development, and manufacturing capabilities while advancing the company’s mission to discover and develop life-changing medicines.

  10. Vetter Prioritizes Continuity And Action In Its Sustainability Efforts 5/6/2025

    Vetter, a leading global contract development and manufacturing organization (CDMO) published its fourth annual sustainability report. The report shows that the family-owned business is actively pursuing ambitious sustainability goals in climate protection, social responsibility, and business operations in a successful manner.